Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Apixaban | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Apixaban | hsa00071 | Fatty acid degradation | 3.50E-02 | 4 | O75521, P00325, P11766, P33121 | ECI2, ADH1B, ADH5, ACSL1 | More | | Apixaban | hsa00380 | Tryptophan metabolism | 1.33E-02 | 2 | P46952, P51648 | HAAO, ALDH3A2 | More | | Apixaban | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Apixaban | hsa00562 | Inositol phosphate metabolism | 1.91E-02 | 3 | P27987, Q13572, Q96PE3 | ITPKB, ITPK1, INPP4A | More | | Apixaban | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Apixaban | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Apixaban | hsa00600 | Sphingolipid metabolism | 2.44E-02 | 2 | Q9BX95, Q06136 | SGPP1, FVT1 | More | | Apixaban | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.34E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Apixaban | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Apixaban | hsa00830 | Retinol metabolism | 2.20E-02 | 4 | P00325, P11766, Q9BPW9, O75911 | ADH1B, ADH5, DHRS9, DHRS3 | More | | Apixaban | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Apixaban | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Apixaban | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Apixaban | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Apixaban | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Apixaban | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Apixaban | hsa03013 | RNA transport | 2.35E-05 | 10 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF4A2, EIF4B, TACC3 | More | | Apixaban | hsa03040 | Spliceosome | 1.87E-03 | 10 | Q14562, O60508, P17844, P08579, P51991, P61978, Q15365, Q01130, P11142, O43447 | DHX8, CDC40, DDX5, SNRPB2, HNRPA3, HNRPK, PCBP1, SFRS2, HSPA8, PPIH | More | | Apixaban | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Apixaban | hsa03060 | Protein export | 3.37E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Apixaban | hsa03450 | Non-homologous end-joining | 3.17E-03 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Apixaban | hsa04020 | Calcium signaling pathway | 1.92E-03 | 6 | P27987, Q16566, P30679, O15399, P23634, P49767 | ITPKB, CAMK4, GNA15, GRIN2D, ATP2B4, VEGFC | More | | Apixaban | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Apixaban | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Apixaban | hsa04064 | NF-kappa B signaling pathway | 7.84E-04 | 15 | O00463, P14778, P01584, P01375, P19174, Q04759, Q13077, Q16548, P06239, Q8WV28, P24522, P09341, P19875, Q06643, Q9NQC7 | TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, TRAF1, BCL2A1, LCK, BLNK, GADD45A, CXCL1, CXCL2, LTB, CYLD | More | | Apixaban | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Apixaban | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Apixaban | hsa04141 | Protein processing in endoplasmic reticulum | 6.04E-03 | 8 | P18848, Q15437, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Apixaban | hsa04151 | PI3K-Akt signaling pathway | 9.80E-03 | 10 | O43521, P27348, Q13362, P07900, P22105, P23458, Q99941, P18848, O00141, Q6ZUJ8 | BCL2L11, YWHAQ, PPP2R5C, HSP90AA1, TNXB, JAK1, CREBL1, ATF4, SGK, PIK3AP1 | More | | Apixaban | hsa04211 | Longevity regulating pathway | 4.57E-02 | 4 | P51828, Q99941, P18848, Q96RR4 | ADCY7, CREBL1, ATF4, CAMKK2 | More | | Apixaban | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Apixaban | hsa04217 | Necroptosis | 3.22E-04 | 11 | P01568, P23458, Q13489, Q9NQC7, Q13546, P07900, P05141, P01584, Q6FI13, Q9H444, O75351 | IFNA21, JAK1, BIRC3, CYLD, RIPK1, HSP90AA1, SLC25A5, IL1B, H2AC18; H2AC19, CHMP4B, VPS4B | More | | Apixaban | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.26E-02 | 6 | P67936, P51828, Q99941, P18848, Q13362, P23634 | TPM4, ADCY7, CREBL1, ATF4, PPP2R5C, ATP2B4 | More | | Apixaban | hsa04371 | Apelin signaling pathway | 2.95E-02 | 4 | P63218, Q14344, Q13485, Q16566 | GNG5, GNA13, SMAD4, CAMK4 | More | | Apixaban | hsa04380 | Osteoclast differentiation | 2.05E-03 | 12 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P01584, P14778, O75015, Q8WV28, P01375, Q15080, P78324 | CYLD, GAB2, MAPK14, JAK1, LCK, IL1B, IL1R1, FCGR3B, BLNK, TNF, NCF4, SIRPA | More | | Apixaban | hsa04390 | Hippo signaling pathway | 5.79E-03 | 4 | P04628, Q9UJU2, O43623, Q13489 | WNT1, LEF1, SNAI2, BIRC3 | More | | Apixaban | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Apixaban | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Apixaban | hsa04612 | Antigen processing and presentation | 4.78E-02 | 6 | P48382, P26715, P26717, Q13241, O43908, P01375 | RFX5, KLRC1, KLRC2, KLRD1, KLRC4, TNF | More | | Apixaban | hsa04613 | Neutrophil extracellular trap formation | 4.05E-03 | 18 | O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P0C0S5, Q93077, P62807, O60814, P68431, Q15080, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AFZ, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Apixaban | hsa04614 | Renin-angiotensin system | 2.74E-02 | 3 | P15144, P08311, O75787 | ANPEP, CTSG, ATP6AP2 | More | | Apixaban | hsa04621 | NOD-like receptor signaling pathway | 1.38E-03 | 13 | P01584, P07900, P23458, Q9H3M7, Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | IL1B, HSP90AA1, JAK1, TXNIP, ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Apixaban | hsa04623 | Cytosolic DNA-sensing pathway | 5.29E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Apixaban | hsa04625 | C-type lectin receptor signaling pathway | 8.11E-03 | 9 | Q9ULY5, P01584, Q9NQC7, P20749, Q14643, P01375, Q13191, P0DP24, Q16539 | CLEC4E, IL1B, CYLD, BCL3, ITPR1, TNF, CBLB, CALM2, MAPK14 | More | | Apixaban | hsa04640 | Hematopoietic cell lineage | 2.62E-03 | 14 | P13612, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P09564, P13765, P01375, P01584 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF, IL1B | More | | Apixaban | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-05 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | | Apixaban | hsa04657 | IL-17 signaling pathway | 1.56E-02 | 8 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Apixaban | hsa04658 | Th1 and Th2 cell differentiation | 2.95E-05 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, P23458, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, JAK1, RUNX3 | More | | Apixaban | hsa04659 | Th17 cell differentiation | 1.17E-04 | 14 | Q04759, Q16539, P19174, P06239, P14784, P13765, P14778, Q9UL17, P23771, P01584, P07766, P09693, P20963, P23458 | PRKCQ, MAPK14, PLCG1, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, IL1B, CD3E, CD3G, CD247, JAK1 | More | | Apixaban | hsa04660 | T cell receptor signaling pathway | 1.96E-04 | 14 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Apixaban | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Apixaban | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Apixaban | hsa04724 | Glutamatergic synapse | 5.34E-04 | 5 | O15399, P63218, P50151, P15104, Q9NSB8 | GRIN2D, GNG5, GNG10, GLUL, HOMER2 | More | | Apixaban | hsa04725 | Cholinergic synapse | 4.10E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Apixaban | hsa04727 | GABAergic synapse | 1.63E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Apixaban | hsa04730 | Long-term depression | 2.54E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Apixaban | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.14E-04 | 11 | P14778, P01584, P51828, P22694, Q16539, P19174, P42338, Q14643, P24723, Q04759, P0DP24 | IL1R1, IL1B, ADCY7, PRKACB, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM2 | More | | Apixaban | hsa04911 | Insulin secretion | 4.85E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Apixaban | hsa04912 | GnRH signaling pathway | 4.33E-02 | 6 | P51828, Q16539, Q9Y6R4, Q14643, P0DP24, P22694 | ADCY7, MAPK14, MAP3K4, ITPR1, CALM2, PRKACB | More | | Apixaban | hsa04915 | Estrogen signaling pathway | 1.65E-02 | 6 | Q99941, P18848, P51828, P07900, P11142, Q15788 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, NCOA1 | More | | Apixaban | hsa04918 | Thyroid hormone synthesis | 2.50E-02 | 4 | P51828, Q99941, P18848, P05543 | ADCY7, CREBL1, ATF4, SERPINA7 | More | | Apixaban | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Apixaban | hsa04925 | Aldosterone synthesis and secretion | 2.50E-02 | 4 | Q99941, P18848, P51828, P23634 | CREBL1, ATF4, ADCY7, ATP2B4 | More | | Apixaban | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P49407 | PIK3CB, GNG5, GNG10, VEGFC, ARRB1 | More | | Apixaban | hsa04927 | Cortisol synthesis and secretion | 3.29E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Apixaban | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Apixaban | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Apixaban | hsa05033 | Nicotine addiction | 2.54E-02 | 2 | P28472, O15399 | GABRB3, GRIN2D | More | | Apixaban | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Apixaban | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Apixaban | hsa05132 | Salmonella infection | 1.67E-03 | 6 | Q9UJU2, Q13546, Q13489, Q13561, Q13509, P68371 | LEF1, RIPK1, BIRC3, DCTN2, TUBB3, TUBB2C | More | | Apixaban | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Apixaban | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Apixaban | hsa05140 | Leishmaniasis | 2.29E-02 | 9 | P13612, O75015, P23458, P13765, O60603, P01375, P01584, Q16539, Q15080 | ITGA4, FCGR3B, JAK1, HLA-DOB, TLR2, TNF, IL1B, MAPK14, NCF4 | More | | Apixaban | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Apixaban | hsa05144 | Malaria | 2.04E-03 | 6 | P60033, O60603, P01375, P35443, P01584, P26718 | CD81, TLR2, TNF, THBS4, IL1B, KLRK1 | More | | Apixaban | hsa05146 | Amoebiasis | 1.54E-04 | 13 | P01584, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | IL1B, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Apixaban | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Apixaban | hsa05163 | Human cytomegalovirus infection | 4.52E-02 | 7 | P51828, P23458, P01584, P61073, Q13651, Q99941, P18848 | ADCY7, JAK1, IL1B, CXCR4, IL10RA, CREBL1, ATF4 | More | | Apixaban | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Apixaban | hsa05202 | Transcriptional misregulation in cancer | 6.59E-03 | 15 | P17844, P14780, P27930, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | DDX5, MMP9, IL1R2, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | | Apixaban | hsa05203 | Viral carcinogenesis | 4.22E-03 | 9 | Q99941, P18848, P23458, P27348, Q7KZF4, Q15283, P61978, P62807, O60814 | CREBL1, ATF4, JAK1, YWHAQ, SND1, RASA2, HNRPK, HIST1H2BC, H2BC12 | More | | Apixaban | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Apixaban | hsa05217 | Basal cell carcinoma | 7.91E-03 | 5 | Q13635, P04628, P49841, Q9UJU2, P24522 | PTCH1, WNT1, GSK3B, LEF1, GADD45A | More | | Apixaban | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.58E-03 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, P23458, O60603, Q04759, Q16539 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, JAK1, TLR2, PRKCQ, MAPK14 | More | | Apixaban | hsa05321 | Inflammatory bowel disease | 1.21E-02 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, P01584 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL1B | More | | Apixaban | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | |